Concert Pharmaceuticals (CNCE) Surged To A New High After Vertex Deal

Concert Pharmaceuticals (CNCE) announced Monday morning that it has agreed to sell its CTP-656 investigational cystic fibrosis treatment to Vertex Pharmaceuticals (VRTX).

from RTT - Before the Bell http://ift.tt/2mAaqcS
via IFTTT